Add-on Acquisition • Life Science

Leinco Acquires QED Biosciences

On September 3, 2024, Leinco acquired life science company QED Biosciences

Acquisition Context

This is Leinco’s 1st transaction in the Life Science sector.
This is Leinco’s 1st transaction in the United States.
This is Leinco’s 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 3, 2024
Target	QED Biosciences
Sector	Life Science
Buyer(s)	Leinco
Deal Type	Add-on Acquisition

Target Company

QED Biosciences

San Diego, California, United States

QED Biosciences provides antibodies, kits, and recombinant proteins and antigens catering to the diverse needs of the IVD and research communities. QED Biosciences is based in San Diego, California.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Leinco

St. Louis, Missouri, United States

Category	Company
Founded	1992
Sector	Life Science

DESCRIPTION

Leinco is a biotechnology company that is engaged in manufacturing of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents, and other life sciences products. Leinco was founded in 1992 and is based in St. Louis, Missouri.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2024	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2024 M&A